NCT06691061 - The PODIUM Study - a Three-arm Comparison of Target Therapies After Anti-TNFα in Ulcerative Colitis | Biotech Hunter

Enrollment

450

Participants

Timeline

Start Date

August 1, 2023

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions

Ulcerative Colitis (Disorder)

Interventions

DRUG

Vedolizumab

UC patients treated with vedolizumab

DRUG

Ustekinumab - Standard Dosage

UC patients treated with ustekinumab

DRUG

JAK Inhibitor

UC patients treated with JAK inhibitors

Trial Locations (1)

RECRUITING

Humanitas Research Hospital IRCSS, Mialn